Follow on Google News News By Tag * Health Economics * Pharmacoeconomics * Drugs Economics Analysis * Pharmacoeconomics Analysis * Health Budget * Biotechnology * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News |  Health Economics Is Crucial In A World With An Ageing Population & Higher Strain On Health Budgets.Pharmacoeconomics is an area that is increasing importance every year. Health Economics and Outcomes Research 2009 - Leaping the fourth hurdle to achieve pharmaceutical success - 4th - 5th June 2009, BSG Conference Centre, London, UK.
By: Visiongain Ltd. Conference Source: http://www.visiongain.com/ Media Partners: PharmiWeb.com, BIOTECHNOLOGY EUROPE, Future Pharmaceuticals, InPharm Background Info Key Speakers • Professor Wolfgang Meyer-Sabellek, Senior Medical Advisor, AZ Medical Europe • Dr Josephine A. Sollano, Sr. Director, Global Therapeutic, Head Global Health Outcomes, Cardiovascular & Metabolics, GlaxoSmithKline • Dr Patrick Mollon, Associate Director, Global Outcomes Research, Pfizer • Dr Kerstin Uhl-Hochgraeber, Head GHEOR Primary Care, Bayer Schering Pharma • Dr Jorge Mestre-Ferrandiz, Senior Economist, Office of Health Economics • Dr Jacco Keja, VP Global Consulting Services (pricing, reimbursement, HE& OR, market services), Quintiles • Dr Jane Speight, Chartered Health Psychologist and Director, AHP Research • Professor Steven Simoens, Associate Professor, Department of Pharmaceutical Sciences, Leuven Catholic University • Gary Johnson, Managing Director, Inpharmation • Professor Mondher Toumi, Department of decision sciences and health policies, University of Lyon, and President, Creativ-Ceutical • Dr Bernard van den Berg, Department of health sciences, VU University Amsterdam, Department of Economics/CRES, Universitat Pompeu Fabra "Linking the care that people get to the outcomes they experience is key" Pharmacoeconomics is an area that is increasing importance every year. Capped health budgets and rising drug costs have led to the high level of interest in the use of economic analysis for decisions about the purchase and subsidisation of new pharmaceutical products. The key point is to establish the relationship between any improved health outcomes with new drugs (compared with established treatments) to the net costs associated with their use. Health economics is crucial in a world with an ageing population and an ever higher strain on health budgets. Pharmaceutical and biotech companies must be able to measure and prove the value of their products in more sophisticated ways and they must account for many different things. In recent years the burden of proof has fallen squarely on the shoulders of industry and this is unlikely to change. Therefore advancements in pharmacoeconomics and greater understanding of health outcomes and the broader context of health economics is essential. Visiongain's Health Economics and Outcomes Research 2009 provides the ideal forum for industry decision-makers, pharmacoeconomic analysts and academics alike to keep up with the latest developments in thinking and practice. By attending this conference you will: • Apply the latest methodological approaches and tools to optimise your pharmacoeconomic analyses • Move beyond methodology and apply insights from related disciplines that can breathe new life into your analyses • Implement insights from developing pharmacoeconomic models in complicated and rapidly-evolving therapeutic areas defined by their complexity • Address the broader societal context and take insights from case studies of success and failure • Tackle common problems facing all pharmacoeconomics, communicate better with payers and develop analyse that provide win-win solutions Target Audience: • Branded Biotechnology Companies • Pharmaceutical Companies • Branded Generics Firms • Health Economics/Outcomes Service Providers • Regulatory Bodies • Academic Organisations Target Audience: • Pharmaceutical and Biotech Companies • Health Research Organisations • Regulatory Bodies • Clinical Practice and Managed Care • Academia Who will be there: VP’s, Directors, Heads and Managers of: • Health Economics • Outcomes Research • Pharmacoeconomics • Market Access • Value Demonstration • Health Metrics & Evaluation • Local and international economic strategy • Pricing & Reimbursement • Strategy Analysis • Medical Affairs • Medical Information • Evidence Based Medicine • Epidemiology Project Management • Regulatory Affairs and Compliance • Clinical Pharmacology • Sales & Marketing Visiongain ltd. 4th Floor, BSG House, 226 236 City Road, London EC1V 2QY United Kingdom Telephone: +44 (0) 20 7336 6100 Fax: +44 (0) 20 7549 9930 info@visiongainglobal.com Or Visit at: http://www.visiongain.com/ Or http://www.visiongain.com Or Contact Person Suvitha Damodaran suvitha.damodaran@ Direct Line: +44 (0)20 7549 9946 +44 (0)20 7336 6100 # # # Visiongain is an independent business information provider for the Telecoms, Pharmaceutical and Defence industries. We organise conferences, publish reports and newsletters, and provide consultancy services. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
